Litcius/Paper detail

Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/PPAR-γ/NF-κB/ROS signaling pathways

Shen Cao, Baojiang Lv, Tai Yi, Hong Xiang Zuo, Yue Xing, Young‐Joon Surh, Ming Yue Li, Juan Ma, Xuejun Jin

2025Toxicology and Applied Pharmacology18 citationsDOI

Topics & Concepts

MAPK/ERK pathwayNF-κBSignal transductionFormononetinChemistryPeroxisome proliferator-activated receptorCell biologyPharmacologyMedicineBiologyReceptorBiochemistryInternal medicineDaidzeinGenisteinInflammatory Bowel DiseaseInflammasome and immune disordersGut microbiota and health
Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/PPAR-γ/NF-κB/ROS signaling pathways | Litcius